Pulmonary, Critical Care, and Sleep Medicine
Pulmonary, Critical Care, and Sleep Medicine
Pulmonary Vascular Disease Program
Pulmonary Vascular Disease Program specializes in the care of patients with diseases that involve the blood supply of the lung. These diseases include pulmonary hypertension, thromboembolic disease, pulmonary vasculitis, etc.
Treatment options for these diseases have multiplied in recent years. For example, there are now 6 approved therapies for pulmonary arterial hypertension including epoprostenol (Flolan), bosentan (Tracleer), treprostinil (Remodulin), iloprost (Ventavis) sildenafil (Revatio/Viagra), and ambrisentan (Letairis).
At least 6 other drugs are in development for PAH, including sitaxsentan (Thelin), actelion-1, inhaled (Viveta) and oral treprostinil, tadalafil (Cialis), vasoactive intestinal peptide, and imatinib (Gleevec).
The Pulmonary Vascular Disease Program evaluates and treats patients with complicated diseases, enrolls them in randomized clinical trials when appropriate, and works in conjunction with the Lung Transplant Program when medical therapies are no longer effective.
Location & Clinic Timing
The Pulmonary Vascular Disease Clinic is located in Internal Medicine and Medical Specialties Clinic on the 3rd floor of the Shands Medical Plaza. The clinics are held Tuesdays and Wednesdays from 1 pm to 5 pm. How to make an Appointment
How to make an Appointment
New patients as well as returning patients need to call 352.265.0139
Medical Professionals
- Kamal Mubarak, M.D, FCCP, Director, Pulmonary Vascular Disease Program
- Hassan Alnuaimat, MD, Associate Director, Pulmonary Vascular Disease Program
- Palma Schmidt, ARNP.